Significance of dyslipidemia for primary open-angle glaucoma

QR Code

Significance of dyslipidemia for primary open-angle glaucoma

Reduction of intraocular pressure is currently considered as the main strategy to stop or slow down the progression of glaucomatous optic neuropathy. However, this goal is achieved in only 1 in 7 patients with primary open-angle glaucoma (POAG). Therefore, it is important to determine further risk f...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	C. Erb, A. Kim
Hōputu:	Tuhinga
Reo:	Ruhiana
I whakaputaina:	Real Time Ltd 2022-09-01
Rangatū:	Российский офтальмологический журнал
Ngā marau:	glaucoma dyslipidemia mitochondriopathy neuroinflammation
Urunga tuihono:	https://roj.igb.ru/jour/article/view/1064
Tags:	Tāpirihia he Tūtohu No Tags, Be the first to tag this record!

Ngā tūemi rite

SMOKING AS AN UNFAVORABLE LIFESTYLE FACTOR FOR THE PROGRESSION OF PRIMARY OPEN-ANGLE GLAUCOMA
mā: Clivia Erb, me ētahi atu.
I whakaputaina: (2025-06-01)

Latanoprost in the treatment of primary open-angle glaucoma
mā: S. Yu. Petrov, me ētahi atu.
I whakaputaina: (2024-12-01)

Possibilities of Preservative-Free Therapy for Primary Open-Angle Glaucoma
mā: A. A. Antonov, me ētahi atu.
I whakaputaina: (2023-12-01)

A new algorithm of treatment choice in primary open-angle glaucoma
mā: A. A. Antonov, me ētahi atu.
I whakaputaina: (2022-01-01)

A spectrofluorimetric study of the limbal area in patients with primary open-angle glaucoma
mā: V. V. Neroev, me ētahi atu.
I whakaputaina: (2022-01-01)

Xalatan in the Treatment of Primary Open-Angle Glaucoma. Review
mā: I. A. Loskutov, me ētahi atu.
I whakaputaina: (2023-12-01)

Possibilities of Preservative-Free Therapy for Primary Open-Angle Glaucoma
mā: S. V. Yanchenko, me ētahi atu.
I whakaputaina: (2023-12-01)

Effectiveness of glaucoma surgery in preserving corneal transparency in patients with primary open-angle glaucoma
mā: Saadet Gültekin Irgat, me ētahi atu.
I whakaputaina: (2025-10-01)

Latanoprost/timolol fixed combination in the treatment of primary open-angle glaucoma
mā: S. Yu. Petrov, me ētahi atu.
I whakaputaina: (2025-03-01)

A Comparison of All-Cause Mortality in Patients Who Required Glaucoma Surgery for Neovascular Glaucoma or Primary Open-Angle Glaucoma: A Retrospective Cohort Study
mā: Laura D. Palmer, me ētahi atu.
I whakaputaina: (2025-06-01)

Comparative Evaluation of the Efficacy and Safety of Primary Trabeculectomy and Drug Therapy in Patients with Advanced Open-angle Glaucoma
mā: S. U. Kasumov, me ētahi atu.
I whakaputaina: (2025-06-01)

Efficacy and safety of ab-externo radiofrequency sclerostomy in management of open-angle glaucoma
mā: M. Abd El Latief Fathallah, me ētahi atu.
I whakaputaina: (2023-10-01)

Micropulse cyclophotocoagulation in the treatment of primary open-angle glaucoma and congenital glaucoma. Part 1: hypotensive effect mechanisms, modern procedure protocol
mā: O. V. Ermakova, me ētahi atu.
I whakaputaina: (2024-12-01)

Eye-Tracking Algorithm for Early Glaucoma Detection: Analysis of Saccadic Eye Movements in Primary Open-Angle Glaucoma
mā: Cansu Yuksel Elgin
I whakaputaina: (2025-05-01)

Polymorphism of proinflammatory inerleukin genes in primary open-angle glaucoma
mā: L. Yu. Barycheva, me ētahi atu.
I whakaputaina: (2024-01-01)

Morphofunctional Studies in the Early Diagnosis of Primary Open-Angle Glaucoma
mā: E. E. Kazaryan, me ētahi atu.
I whakaputaina: (2018-10-01)

Nonpharmacological Strengthening of Fibrinolysis in Complex Therapy of Primary Open-Angle Glaucoma
mā: S. I. Makogon, me ētahi atu.
I whakaputaina: (2020-04-01)

Therapeutic and preventive eff ect of physical exercises in primary open-angle glaucoma
mā: E. V. Kozina, me ētahi atu.
I whakaputaina: (2021-12-01)

Content of matrix metalloproteinases in the intraocular fluid of patients with primary open-angle glaucoma
mā: V. V. Chernykh, me ētahi atu.
I whakaputaina: (2020-11-01)

Single-step primary open-angle glaucoma and complicated cataract surgery using modified technique of stainless steel Glaucoma Filtration Device implantation
mā: J. A. Gusev, me ētahi atu.
I whakaputaina: (2014-07-01)

Single-step primary open-angle glaucoma and complicated cataract surgery using modified technique of stainless steel Glaucoma Filtration Device implantation
mā: I. L Bessonov, me ētahi atu.
I whakaputaina: (2014-07-01)

A Personalized Approach to the Treatment of Primary Open-Angle Glaucoma
mā: A. L. Onishchenko, me ētahi atu.
I whakaputaina: (2021-10-01)

Optical Coherence Tomography in the Diagnosis of Open-angle Glaucoma
mā: Yu. N. Yusef, me ētahi atu.
I whakaputaina: (2024-12-01)

EX-PRESS DRAINAGE DEVICE IN PATIENTS WITH REFRACTORY AND PRIMARY OPEN-ANGLE GLAUCOMA
mā: M. M. Bikbov, me ētahi atu.
I whakaputaina: (2016-11-01)

The effectiveness of complex treatment of endothelial dysfunction in patients with primary open angle glaucoma
mā: A. M. Dusmukhamedova, me ētahi atu.
I whakaputaina: (2024-10-01)

Early outcomes of 5-0 prolene gonioscopy-assisted transluminal trabeculotomy in juvenile open-angle glaucoma
mā: Devendra Maheshwari, me ētahi atu.
I whakaputaina: (2025-06-01)

Violation of the vascular platelet hemostasis as a risk factor of primary open-angle glaucoma progression
mā: N. I. Kurysheva, me ētahi atu.
I whakaputaina: (2015-10-01)

The Connectivity of the Resting Brain in Primary Open-Angle Glaucoma: A Systematic Review
mā: Nikola Velkov, me ētahi atu.
I whakaputaina: (2025-06-01)

Analysis of the circadian rhythm of intraocular pressure in stable and progressive forms of primary open-angle glaucoma
mā: T. N. Malishevskaya, me ētahi atu.
I whakaputaina: (2019-12-01)

Facilities of diagnosis and monitoring of optic neuropathy in primary open-angle glaucoma. Part 2
mā: O. A. Kiseleva, me ētahi atu.
I whakaputaina: (2020-03-01)

Some Aspects of Vascular Theory of Development and Progression of Primary Open-Angle Glaucoma (Literature Review). Part 1
mā: S. I. Makogon, me ētahi atu.
I whakaputaina: (2019-03-01)

The efficiency of monotherapy of patients with primary open-angle glaucoma with Bimatoprost 0.03 % (Bimoptic)
mā: S. A. Korotkikh, me ētahi atu.
I whakaputaina: (2018-12-01)

Features of the complement system in primary open-angle glaucoma and dry eye syndrome in the elderly
mā: N. M. Agarkov, me ētahi atu.
I whakaputaina: (2022-04-01)

Diagnosis and prediction ofprimary open-angle glaucoma by the level of local cytokine
mā: N. M. Agarkov, me ētahi atu.
I whakaputaina: (2020-01-01)

Impact of Oral Citicoline, Antioxidant Vitamins, and Blackcurrant Supplementation on Primary Open-Angle Glaucoma: An OCT and OCTA Study
mā: Piera Giunta, me ētahi atu.
I whakaputaina: (2025-05-01)

The compliance of specialized medical care of patients with glaucoma to clinical recommendations (CR 96/1 “Primary open-angle glaucoma”) in Russian Federation regions
mā: V. V. Neroev, me ētahi atu.
I whakaputaina: (2024-03-01)

The Comparative Study of the Results of Visualization of the Anterior Chamber Angle of the Eye in the Primary Angle Closure Disease and Primary Open Angle Glaucoma
mā: N. I. Kurysheva, me ētahi atu.
I whakaputaina: (2025-06-01)

PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS
mā: A. Yu. Kulikov, me ētahi atu.
I whakaputaina: (2015-03-01)

Сompatibility of Systemic Drugs and Local Antihypertensive Therapy in Patients with Primary Open-Angle Glaucoma (Analytical Review)
mā: V. P. Erichev, me ētahi atu.
I whakaputaina: (2019-01-01)

Structural and Functional Correlations in Patients with Advanced Stages of Primary Open-Angle Glaucoma
mā: V. I. Kotelin, me ētahi atu.
I whakaputaina: (2021-07-01)